Latest Regulatory Compliance News

WT Financial Group reports robust FY2025 growth driven by a scalable adviser network and a strategic joint venture with Merchant Wealth Partners, positioning itself for further consolidation in Australia’s financial advice sector.

360 Capital Mortgage REIT has confirmed comprehensive compliance with ASX corporate governance principles for FY2025, with a single noted exception regarding board chair independence.

Dundee Precious Metals has secured the Bosnian Competition Council's approval, clearing a major regulatory hurdle in its planned acquisition of Adriatic Metals. The deal now moves closer to completion pending shareholder and court approvals.

Emu NL has lodged a formal review application against the Takeovers Panel's recent variation of orders, signaling continued regulatory tension in its takeover proceedings.

ASX has revealed it expects to incur an additional $25 million to $35 million in operating expenses in FY26 due to the ongoing ASIC compliance inquiry. Despite this, the company remains committed to its five-year strategy focused on technology and risk management.

AMP Limited reported a modest increase in underlying net profit after tax to $236 million for the first half of 2025, supported by steady revenues and disciplined cost management across its key business units.

AMP Limited has announced an ordinary dividend of AUD 0.02 per share for the six months ending June 2025, with a 20% franking credit, payable in late September.

Key Petroleum has completed a $152,361 placement, issuing over 3.6 million shares to a sophisticated investor to support merger preparations and working capital needs.

Lowell Resources Fund (ASX – LRT) has announced a 12-month on-market unit buy-back of up to 10% of its units, aiming to boost unitholder returns and capital efficiency without compromising future growth.

Rhythm Biosciences has responded to an ASX price query following a sudden surge in its share price and trading volume, confirming no undisclosed information is driving the activity.

Finexia Financial Group has ended talks on a major disposal deal and is managing loan defaults with fresh collateral, while expanding its childcare lending strategy.

Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.